RESUMEN
We have evaluated eight p-coumaric acid prenylated derivatives inâ vitro for their antileishmanial activity against Leishmania amazonensis promastigotes and their antischistosomal activity against Schistosoma mansoni adult worms. Compound 7 ((E)-3,4-diprenyl-4-isoprenyloxycinnamic alcohol) was the most active against L. amazonensis (IC50=45.92â µM) and S. mansoni (IC50=64.25â µM). Data indicated that the number of prenyl groups, the presence of hydroxyl at C9, and a single bond between C7 and C8 are important structural features for the antileishmanial activity of p-coumaric acid prenylated derivatives.
Asunto(s)
Antiprotozoarios , Ácidos Cumáricos , Leishmania , Pruebas de Sensibilidad Parasitaria , Schistosoma mansoni , Animales , Schistosoma mansoni/efectos de los fármacos , Ácidos Cumáricos/farmacología , Ácidos Cumáricos/química , Leishmania/efectos de los fármacos , Antiprotozoarios/farmacología , Antiprotozoarios/química , Antiprotozoarios/síntesis química , Relación Estructura-Actividad , Prenilación , Propionatos/farmacología , Propionatos/química , Estructura Molecular , Esquistosomicidas/farmacología , Esquistosomicidas/química , Esquistosomicidas/síntesis química , Relación Dosis-Respuesta a DrogaRESUMEN
ABSTRACT Introduction: Schistosomiasis is an infectious parasitic disease caused by trematodes of the genus Schistosoma, which threatens at least 258 million people worldwide and its control is dependent on a single drug, praziquantel. The aim of this study was to evaluate the anti-Schistosoma mansoni activity in vitro of novel imidazolidine derivatives. Material and methods: We synthesized two novel imidazolidine derivatives: (LPSF/PTS10) (Z)-1-(2-chloro-6-fluorobenzyl)-4-(4-dimethylaminobenzylidene)-5-thioxoimidazolidin-2-one and (LPSF/PTS23) (Z)-1-(2-chloro-6-fluoro-benzyl)-5-thioxo-4-(2,4,6-trimethoxy-benzylidene)-imidazolidin-2-one. The structures of two compounds were determined by spectroscopic methods. During the biological assays, parameters such as motility, oviposition, mortality and analysis by Scanning Electron Microscopy were performed. Results: LPSF/PTS10 and LPSF/PTS23 were considered to be active in the separation of coupled pairs, mortality and to decrease the motor activity. In addition, LPSF/PTS23 induced ultrastructural alterations in worms, after 24 h of contact, causing extensive erosion over the entire body of the worms. Conclusion: The imidazolidine derivatives containing the trimetoxy and benzylidene halogens showed promising in vitro schistosomicidal activity.
Asunto(s)
Humanos , Animales , Ratones , Imidazolidinas/farmacología , Células Madre de Sangre Periférica/efectos de los fármacos , Schistosoma mansoni/efectos de los fármacos , Esquistosomicidas/farmacología , Imidazolidinas/síntesis química , Imidazolidinas/toxicidad , Microscopía Electrónica de Rastreo , Pruebas de Sensibilidad Parasitaria , Schistosoma mansoni/ultraestructura , Esquistosomicidas/síntesis química , Esquistosomicidas/toxicidad , Factores de TiempoRESUMEN
The emergence of strains of Schistosoma resistant to praziquantel has drawn attention to the search for new schistosomacide drugs. Imidazolidinic derivatives have performed outstandingly against adult S. mansoni worms when evaluated in vitro. The molecular modification of imidazolidine by way of bioisosteric replacement gives rise to variations in its biological response. This study verifies the potential of substituent groups in the derivatives (Z)3-benzyl-5-(2-fluoro-benzylidene)-imidazolidine-2,4-dione NE4, 3-benzyl-5-(4-chloro-arylazo)-4-thioxo-imidazolidin -2-ona PT5, 3-benzyl-5-(3-fluoro-benzylidene)-1-methyl-2-thioxo-imidazolidin-4-one JT53; 3-benzyl-1-methyl-5-(4-methyl-benzylidene)-2-thioxo-imidazolidin-4-one JT63; 3-benzyl-1-methyl-5-(4-methoxi-benzylidene)-2-thioxo -imidazolidin-4-one JT68; 3-(4-chloro-benzyl)-1-methyl-5-(4-methoxi-benzylidene)-2-thioxo-imidazolidin-4-one JT69; 3-(4-phenyl-benzyl)-1-methyl-5-(4-methoxi-benzylidene)-2-thioxo-imidazolidin-4-one JT72 by determining the viability in vitro of adult S. mansoni worms in the presence of these derivatives. The susceptibility of the worms obtained from mice and kept in culture in the presence of different concentrations was determined by way of schistosomacide kinetic, observed every 24 h over a period of eight days. The results show that the worms were more sensitive to the PT5 derivative at a concentration of 58 æM which killed 100 percent of the worms after 24 h of contact, also giving rise to alterations in the tegument surface of the worms with the formation of bubbles and peeling. These observations suggest a strong electronic contribution of the arylazo grouping in the biological response.
Asunto(s)
Animales , Femenino , Masculino , Ratones , Imidazolidinas/farmacología , Schistosoma mansoni/efectos de los fármacos , Esquistosomicidas/farmacología , Imidazolidinas/síntesis química , Pruebas de Sensibilidad Parasitaria , Esquistosomicidas/síntesis química , Factores de TiempoRESUMEN
Se reporta la preparación y acción esquistosomicida de nuevos profármacos obtenidos mediante la reacción de Mannich. Se emplearon en la formación de las bases de Mannich cantidades equimoleculares de praziquantel y distintos compuestos amínicos como benznidazol, morfolina, oxamniquina y piperazina con solución de formaldehido. Los productos obtenidos fueron analizados por microanálisis, espectroscopía al infrarrojo (IR) y resonancia magnética nuclear 1-HRMN. Los pro-fáremacos mostraron mayor liposolubilidad que el fármaco de origen. La actividad esquistosomicida en cepa de Schistosoma mansoni fue determinada experimentalmente en ratones. In vivo fue comprobada la mayor actividad schistosomicida de tres de los profármacos sintetizados en comparación con el sustrato no modificado